Moreover, CQ could also be applied in the therapy of malignant diseases with deregulated AP-1 pathway activity, as found in non-small cell lung cancers, colorectal or breast cancers43, 44, 45, 46, 47. The gene discussed is JUN; the disease is non-small cell lung carcinoma.